Sumitomo Pharmaceuticals Company Limited

Sumitomo Chemical Company, Limited

Ikutaro Saji

Mayumi Yoshigi

Norihiko Tanno

Fujio Antoku

Takao Okuda

Atsuyuki Kojima

Shunji Aono

Hideo Agui

Masayuki Muto

Katsuaki Ichise

Kukuo Ishizumi

Hiroshi Yamazaki

Yoshihiro Tanaka

Kikuo Ishizumi

Toshio Atsumi

Hiroaki Masumori

Mitsuo Nakashita

Yoshihiko Kimura

Noritaka Hanma

Yasuo Motoike

Renzo Sato

Tomoharu Tanio

An imide compound of the formula: ##STR1## wherein Z is a group of the formula: ##STR2## in which B is a carbonyl group or a sulfonyl group, R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are each a hydrogen atom or a lower alkyl group, or R.sup.1 and R.sup.2 or R.sup.1 and R.sup.3 may be combined together to make a non-aromatic hydrocarbon ring or R.sup.1 and R.sup.3 may be combined together to make an aromatic ring, said non-aromatic hydrocarbon ring being optionally bridged with a lower alkylene group or an oxygen atom therein and said aromatic ring, said non-aromatic hydrocarbon ring and said lower alkylene group being each optionally substituted with at least one lower alkyl, and n is an integer of 0 or 1;

Imide derivatives and their production and use

An imide compound of the formula: ##STR1## wherein Z is a group of the formula: ##STR2## in which the substituents are defined herein, and n is an integer of 0 to 1;

Imide derivatives, and their production and use

A novel thiazole derivative represented by the following general formula [1] and a pharmaceutically acceptable salt thereof: ##STR1## wherein A is a single bond, a straight-chained or branched lower alkylene group or a straight-chained or branched lower alkenylene group; B is a single bond or --CO--; R.sup.1 is a carboxy group or --CON(R.sup.7)OR.sup.8 (R.sup.7 and R.sup.8 are independently of each other a hydrogen atom or a lower alkyl group); R.sup.2 is a lower alkyl group; R.sup.3 and R.sup.4 are independently of each other a hydrogen atom, a lower alkyl group or a lower alkoxycarbonyl group; R.sup.5 is a hydrogen atom or a halogen atom; and R.sup.6 is a hydrogen atom, a halogen atom, a lower alkyl group, a hydroxy group, a lower alkoxy group, a thiol group, a lower alkylthio group, a lower alkylsulfinyl group, a lower alkylsulfonyl group, a nitro group, an amino group, a substituted amino group, a cyano group, a carboxy group or an acyl group. The compounds of the present invention are useful as therapeutic or preventive drugs for autoimmune diseases and inflammatory diseases.

Thiazole derivatives

An N-substituted triazole compound of the formula: ##STR1## wherein Ph is a phenyl group or a phenyl group substituted with one or two halogen atoms, R.sup.1 is a C.sub.1 -C.sub.3 alkyl group, R.sup.2 is a hydrogen atom or a C.sub.1 -C.sub.3 alkyl group, R.sup.3 is a C.sub.1 -C.sub.8 alkyl group, a C.sub.4 -C.sub.8 cycloalkylalkyl group or a C.sub.3 -C.sub.6 cycloalkyl group and n is 0, 1 or 2, or an acid addition salt thereof, which is useful as an antifungal agent.

N-substituted triazole derivatives and fungicidal use thereof

An imide derivative of the formula: ##STR1## or a pharmaceutically acceptable salt, which is useful as an antipsychotic drug.

Imide derivatives, and their use in pharmaceuticals

A compound of the formula: ##STR1## or its acid addition salt, which is useful as a psychotic drug.

Imide derivatives and their pharmaceutical use

Imide derivatives and their use in the treatment psychosis

An optically active imidazolylpropanol compound of the formula: ##STR1## wherein n is an integer of 3 or 4, and its acid addition salts, which is useful as an antifungal agent, prepared by reacting an imidazolylthiol of the formula: ##STR2## with an alkylating agent of the formula:

Process for preparing optically active imidazolylpropanol compounds, and

An imidazolylcarboxylic acid compound of the formula: ##STR1## wherein Ph is a phenyl group or a phenyl group substituted with one or two halogen atoms, R is a hydrogen atom or a C.sub.1 -C.sub.8 alkyl group and n is an integer of 1 to 8, which is useful as an antifungal agent.

Antifungal imidazolylcarboxylic acids and their derivatives

An N-substituted imidazole compound of the formula: ##STR1## wherein R and R' are independently a phenyl group optionally substituted with one or more halogen, C.sub.1 -C.sub.8 alkyl, C.sub.1 -C.sub.8 alkoxy, C.sub.1 -C.sub.8 alkylthio, phenyl, phenoxy, phenylthio, hydroxyl, trifluoromethyl, amino, carbamoyl, di(C.sub.1 -C.sub.8) alkylamino, C.sub.1 -C.sub.8 alkanoylamino, nitro, cyano, carboxy, C.sub.1 -C.sub.8 alkoxycarbonyl, C.sub.1 -C.sub.8 alkylsulfonyloxy or C.sub.1 -C.sub.8 alkanoylpiperazino groups; a C.sub.1 -C.sub.15 alkyl group or a phenyl (C.sub.1 -C.sub.2) alkyl group optionally bearing halogen on the benzene ring, and its acid-addition salts, which is useful as an antifungal agent.

N-Substituted imidazole derivatives, and their use

A process for preparing N-tritylimidazole compounds of the formula: ##STR1## by the reaction between a tritylcarbinol derivative of the formula: ##STR2## and an imidazole derivative of the formula: ##STR3## , characterized in that the reaction is effected in the presence of a phosphorus compound of the formula: ##STR4##

Growing community of inventors

Osaka, Japan

Ikutaro Saji